139 related articles for article (PubMed ID: 6777812)
61. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
David SR; Taylor CC; Kinon BJ; Breier A
Clin Ther; 2000 Sep; 22(9):1085-96. PubMed ID: 11048906
[TBL] [Abstract][Full Text] [Related]
62. The prolactin response to flutroline hydrochloride in schizophrenic patients.
Kurland AA; Nagaraju A; Hanlon TE; Williams TG
J Clin Pharmacol; 1983; 23(11-12):505-16. PubMed ID: 6141186
[TBL] [Abstract][Full Text] [Related]
63. Late (4-8 years) outcome of treatment with megadoses of fluphenazine enanthate in drug-refractory schizophrenics.
Dencker SJ; Enoksson P; Johansson R; Lundin L; Malm U
Acta Psychiatr Scand; 1981 Jan; 63(1):1-12. PubMed ID: 7234461
[TBL] [Abstract][Full Text] [Related]
64. Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics.
Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
Schizophr Res; 2013 Apr; 145(1-3):116-9. PubMed ID: 23375624
[TBL] [Abstract][Full Text] [Related]
65. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
[TBL] [Abstract][Full Text] [Related]
66. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
Markianos M; Hatzimanolis J; Lykouras L
Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
[TBL] [Abstract][Full Text] [Related]
67. Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.
Marder SR; Midha KK; Van Putten T; Aravagiri M; Hawes EM; Hubbard JW; McKay G; Mintz J
Br J Psychiatry; 1991 May; 158():658-65. PubMed ID: 1860020
[TBL] [Abstract][Full Text] [Related]
68. 50 kD prolactin binding protein in schizophrenics on neuroleptic medication.
Walker AM; Peabody CA; Ho TW; Warner MD
J Psychiatry Neurosci; 1992 Jun; 17(2):61-7. PubMed ID: 1353370
[TBL] [Abstract][Full Text] [Related]
69. The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine.
Meltzer HY; Maes M; Lee MA
Psychopharmacology (Berl); 1993; 112(1 Suppl):S95-104. PubMed ID: 7831446
[TBL] [Abstract][Full Text] [Related]
70. The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate.
Midha KK; Hubbard JW; Marder SR; Hawes EM; Van Putten T; McKay G; May PR
Psychopharmacology (Berl); 1987; 93(3):369-73. PubMed ID: 3124166
[TBL] [Abstract][Full Text] [Related]
71. Release of oxytocin and prolactin by suckling in rabbits throughout lactation.
Fuchs AR; Cubile L; Dawood MY; Jørgensen FS
Endocrinology; 1984 Feb; 114(2):462-9. PubMed ID: 6690286
[TBL] [Abstract][Full Text] [Related]
72. Neuroleptic bioavailability, psychosocial factors, and clinical status: a 1-year study of schizophrenic outpatients after dose reduction.
Faraone SV; Curran JP; Laughren T; Faltus F; Johnston R; Brown WA
Psychiatry Res; 1986 Dec; 19(4):311-22. PubMed ID: 2880360
[TBL] [Abstract][Full Text] [Related]
73. Relapse rate and low serum neuroleptic levels in schizophrenics treated with fluphenazine: another view.
Boza RA; Milanes F; Starkey T; Slater V; Dominguez F
J Clin Psychiatry; 1988 Jun; 49(6):245. PubMed ID: 2897960
[No Abstract] [Full Text] [Related]
74. Fluphenazine plasma levels and clinical response.
Marder SR; Van Putten T; Aravagiri M; Hawes EM; Hubbard JW; McKay G; Mintz J; Midha KK
Psychopharmacol Bull; 1990; 26(2):256-9. PubMed ID: 2236467
[TBL] [Abstract][Full Text] [Related]
75. Differential effect of low and conventional doses of fluphenazine on schizophrenic outpatients with good or poor information-processing abilities.
Asarnow RF; Marder SR; Mintz J; Van Putten T; Zimmerman KE
Arch Gen Psychiatry; 1988 Sep; 45(9):822-6. PubMed ID: 3046554
[TBL] [Abstract][Full Text] [Related]
76. High vs standard dosage fluphenazine HCL in acute schizophrenia.
Donlon PT; Meadow A; Tupin JP; Wahba M
J Clin Psychiatry; 1978 Nov; 39(11):800-4. PubMed ID: 363702
[TBL] [Abstract][Full Text] [Related]
77. Neurochemical studies on tardive dyskinesia. I. Urinary homovanillic acid and plasma prolactin.
Tripodianakis J; Markianos M; Garelis E
Biol Psychiatry; 1983 Mar; 18(3):337-45. PubMed ID: 6132625
[TBL] [Abstract][Full Text] [Related]
78. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance.
Akiyama K; Tsuchida K; Kanzaki A; Ujike H; Hamamura T; Kondo K; Mutoh S; Miyanagi K; Kuroda S; Otsuki S
Biol Psychiatry; 1995 Nov; 38(10):639-48. PubMed ID: 8555375
[TBL] [Abstract][Full Text] [Related]
79. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
[TBL] [Abstract][Full Text] [Related]
80. Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels.
Baron JC; Martinot JL; Cambon H; Boulenger JP; Poirier MF; Caillard V; Blin J; Huret JD; Loc'h C; Maziere B
Psychopharmacology (Berl); 1989; 99(4):463-72. PubMed ID: 2574481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
